Auranofin and pharmacologic ascorbate as radiomodulators in the treatment of pancreatic cancer

HIGHLIGHTS

  • who: Garett J. Steers and colleagues from the Free Radical and Radiation Biology Program, Department of Radiation Oncology, The University of Iowa Department of Surgery, The University of Iowa Carver College of Medicine, Iowa City, IA, USA have published the Article: Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer, in the Journal: Antioxidants 2022, 971 of /2022/
  • what: Pancreatic cancer continues to carry an extremely poor prognosis and remains the third-leading cause of cancer deaths, despite advances in chemotherapy and radiation protocols.
  • future: Little progress in the development . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?